AnaptysBio Inc
NASDAQ:ANAB
AnaptysBio Inc
NASDAQ:ANAB
Price:
55.05
USD
-1.89%
Market Closed
Market Cap:
$1.5B
Balance Sheet
Balance Sheet Decomposition
AnaptysBio Inc
AnaptysBio Inc
Balance Sheet Decomposition is not available for
AnaptysBio Inc
AnaptysBio Inc
Balance Sheet
AnaptysBio Inc
AnaptysBio Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
3
|
22
|
52
|
51
|
81
|
114
|
171
|
251
|
496
|
71
|
36
|
123
|
|
| Cash Equivalents |
3
|
22
|
52
|
51
|
81
|
114
|
171
|
251
|
496
|
71
|
36
|
123
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
167
|
314
|
203
|
143
|
52
|
370
|
355
|
262
|
|
| Total Receivables |
0
|
2
|
1
|
5
|
2
|
0
|
0
|
0
|
1
|
1
|
7
|
41
|
|
| Other Current Assets |
0
|
1
|
1
|
2
|
3
|
7
|
4
|
3
|
5
|
5
|
9
|
6
|
|
| Total Current Assets |
3
|
24
|
54
|
58
|
253
|
434
|
378
|
397
|
554
|
447
|
407
|
432
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
1
|
1
|
3
|
2
|
22
|
20
|
18
|
16
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
1
|
1
|
3
|
2
|
22
|
20
|
18
|
16
|
|
| Accumulated Depreciation |
3
|
3
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
6
|
6
|
7
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
76
|
73
|
54
|
18
|
67
|
143
|
27
|
35
|
|
| Other Long-Term Assets |
0
|
0
|
2
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4
N/A
|
25
+544%
|
56
+124%
|
62
+10%
|
329
+430%
|
509
+55%
|
435
-14%
|
417
-4%
|
643
+54%
|
610
-5%
|
452
-26%
|
484
+7%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
0
|
2
|
2
|
2
|
5
|
16
|
4
|
2
|
3
|
5
|
4
|
|
| Accrued Liabilities |
1
|
1
|
3
|
3
|
5
|
9
|
12
|
16
|
14
|
23
|
33
|
41
|
|
| Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
7
|
8
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
10
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
12
|
7
|
6
|
14
|
22
|
30
|
20
|
16
|
26
|
37
|
45
|
|
| Long-Term Debt |
0
|
5
|
5
|
14
|
8
|
1
|
0
|
0
|
0
|
0
|
311
|
353
|
|
| Other Liabilities |
1
|
3
|
2
|
3
|
0
|
0
|
1
|
0
|
271
|
322
|
16
|
14
|
|
| Total Liabilities |
4
N/A
|
19
+403%
|
14
-27%
|
23
+65%
|
22
-5%
|
23
+4%
|
30
+34%
|
20
-34%
|
287
+1 347%
|
348
+22%
|
364
+5%
|
413
+13%
|
|
| Equity | |||||||||||||
| Common Stock |
35
|
37
|
78
|
78
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
49
|
45
|
51
|
55
|
85
|
147
|
244
|
264
|
322
|
451
|
614
|
759
|
|
| Additional Paid In Capital |
14
|
14
|
16
|
17
|
393
|
633
|
649
|
661
|
679
|
718
|
703
|
830
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
1
|
0
|
|
| Total Equity |
0
N/A
|
6
+5 900%
|
42
+605%
|
39
-7%
|
308
+683%
|
486
+58%
|
405
-17%
|
397
-2%
|
356
-10%
|
262
-26%
|
88
-66%
|
71
-20%
|
|
| Total Liabilities & Equity |
4
N/A
|
25
+544%
|
56
+124%
|
62
+10%
|
329
+430%
|
509
+55%
|
435
-14%
|
417
-4%
|
643
+54%
|
610
-5%
|
452
-26%
|
484
+7%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
19
|
19
|
19
|
20
|
24
|
27
|
27
|
27
|
28
|
29
|
27
|
30
|
|
Switch to:
Switch to:
See Also
Discover More
